東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Regulation of biotechnological risks...

Andersen, Elisabeth Anna Lümkea.

Linked to FindBook

Google Book

Amazon

博客來

Regulation of biotechnological risks in a multi-level system = an analysis of the EU regulation of genome edited plants in light of WTO law and CETA /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Regulation of biotechnological risks in a multi-level system/ by Elisabeth Anna Lümkea Andersen.
Reminder of title:	an analysis of the EU regulation of genome edited plants in light of WTO law and CETA /
Author:	Andersen, Elisabeth Anna Lümkea.
Published:	Cham :Springer Nature Switzerland : : 2025.,
Description:	xiv, 310 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction -- Scientific Background -- The European Court of Justice's Decision on Genome Editing -- The Regulation of Genetically Modified Plants in the European Union -- The EU's Obligations under WTO law and CETA -- EU Regulations on Genome Edited Plants under WTO Law and CETA -- The Future of Genome Edited Plants in the EU -- Concluding Remarks -- Summary of Results.
Contained By:	Springer Nature eBook
Subject:	Plant genetic engineering - Law and legislation - European Union countries. -
Online resource:	https://doi.org/10.1007/978-3-032-02409-1
ISBN:	9783032024091

Regulation of biotechnological risks in a multi-level system = an analysis of the EU regulation of genome edited plants in light of WTO law and CETA /
Andersen, Elisabeth Anna Lümkea.

Regulation of biotechnological risks in a multi-level systeman analysis of the EU regulation of genome edited plants in light of WTO law and CETA /[electronic resource] :by Elisabeth Anna Lümkea Andersen. - Cham :Springer Nature Switzerland :2025. - xiv, 310 p. :ill., digital ;24 cm. - EYIEL monographs - studies in European and international economic law,v. 462524-6666 ;. - EYIEL monographs - studies in European and international economic law ;v. 46..

Introduction -- Scientific Background -- The European Court of Justice's Decision on Genome Editing -- The Regulation of Genetically Modified Plants in the European Union -- The EU's Obligations under WTO law and CETA -- EU Regulations on Genome Edited Plants under WTO Law and CETA -- The Future of Genome Edited Plants in the EU -- Concluding Remarks -- Summary of Results.

This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA. Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal. The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.

ISBN: 9783032024091

Standard No.: 10.1007/978-3-032-02409-1doiSubjects--Topical Terms:

3803999
Plant genetic engineering
--Law and legislation--European Union countries.

LC Class. No.: KJE6227

Dewey Class. No.: 344.40957

Regulation of biotechnological risks in a multi-level system = an analysis of the EU regulation of genome edited plants in light of WTO law and CETA /
LDR:02619nmm a22003375a 4500 001 2422310
003 DE-He213
005 20251108120401.0
006 m d
007 cr nn 008maaau
008 260505s2025 sz s 0 eng d
020 $a 9783032024091 $q (electronic bk.)
020 $a 9783032024084 $q (paper)
024 7 $a 10.1007/978-3-032-02409-1 $2 doi
035 $a 978-3-032-02409-1
040 $a GP $c GP
041 0 $a eng
050 4 $a KJE6227
072 7 $a LBBM $2 bicssc
072 7 $a LAW051000 $2 bisacsh
072 7 $a LBBM $2 thema
082 0 4 $a 344.40957 $2 23
090 $a KJE6227 $b .A544 2025
100 1 $a Andersen, Elisabeth Anna Lümkea. $3 3803997
245 1 0 $a Regulation of biotechnological risks in a multi-level system $h [electronic resource] : $b an analysis of the EU regulation of genome edited plants in light of WTO law and CETA / $c by Elisabeth Anna Lümkea Andersen.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2025.
300 $a xiv, 310 p. : $b ill., digital ; $c 24 cm.
490 1 $a EYIEL monographs - studies in European and international economic law, $x 2524-6666 ; $v v. 46
505 0 $a Introduction -- Scientific Background -- The European Court of Justice's Decision on Genome Editing -- The Regulation of Genetically Modified Plants in the European Union -- The EU's Obligations under WTO law and CETA -- EU Regulations on Genome Edited Plants under WTO Law and CETA -- The Future of Genome Edited Plants in the EU -- Concluding Remarks -- Summary of Results.
520 $a This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA. Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal. The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.
650 0 $a Plant genetic engineering $x Law and legislation $z European Union countries. $3 3803999
650 0 $a Transgenic plants $x Risk assessment. $3 663266
650 1 4 $a International Economic Law, Trade Law. $3 1566625
650 2 4 $a European Economic Law. $3 3412422
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a EYIEL monographs - studies in European and international economic law ; $v v. 46. $3 3803998
856 4 0 $u https://doi.org/10.1007/978-3-032-02409-1
950 $a Law and Criminology (SpringerNature-41177)